Data / Drug companies / Olmesartan medoxomil and hydrochlorothiazide
Olmesartan medoxomil and hydrochlorothiazide: 17 companies and 63 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Olmesartan medoxomil and hydrochlorothiazide is listed in the FDA National Drug Code Directory by 17 companies, with 63 products in commercial distribution. 63 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, and the newest product started marketing on October 25, 2026.
The request: Get every company that lists olmesartan medoxomil and hydrochlorothiazide in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 17
- Products
- 63
- Generic (ANDA) products
- 63 (100.0%)
- Application numbers
- 9
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list olmesartan medoxomil and hydrochlorothiazide
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 10 | tablet, film coated; tablet | Generic drugs (ANDA) | June 2, 2023 |
| Bryant Ranch Prepack | 8 | tablet; tablet, film coated | Generic drugs (ANDA) | June 2, 2023 |
| Remedyrepack Inc. | 5 | tablet, film coated; tablet | Generic drugs (ANDA) | October 25, 2026 |
| Accord Healthcare Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | September 21, 2020 |
| Alembic Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | April 24, 2017 |
| Alembic Pharmaceuticals Limited | 3 | tablet | Generic drugs (ANDA) | April 24, 2017 |
| Ascend Laboratories, LLC | 3 | tablet, film coated | Generic drugs (ANDA) | May 1, 2025 |
| Aurobindo Pharma Limited | 3 | tablet, film coated | Generic drugs (ANDA) | April 24, 2017 |
| Camber Pharmaceuticals, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | July 25, 2025 |
| Golden State Medical Supply, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | March 31, 2026 |
| Lifestar Pharma LLC | 3 | tablet | Generic drugs (ANDA) | October 1, 2020 |
| Macleods Pharmaceuticals Limited | 3 | tablet, film coated | Generic drugs (ANDA) | June 2, 2023 |
| NorthStar RxLLC | 3 | tablet, film coated | Generic drugs (ANDA) | April 8, 2024 |
| ScieGen Pharmaceuticals, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | May 19, 2026 |
| Solco Healthcare US, LLC | 3 | tablet | Generic drugs (ANDA) | April 24, 2017 |
| Umedica Laboratories USA Inc. | 3 | tablet | Generic drugs (ANDA) | February 15, 2026 |
| Bryant Ranch Prepack | 1 | tablet | Generic drugs (ANDA) | April 24, 2017 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 38 | 60.3% |
| Tablet | 25 | 39.7% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 63 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Angiotensin 2 Receptor Blocker | 63 |
| Thiazide Diuretic | 63 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.